Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin.
Mona ArbabYu-Hui ChenShana CriscitielloJason GlassJo Ann FugazzottoJoseph H KilloranGlenn HannaJochen LorchRobert I HaddadDanielle N MargalitRoy B TishlerJonathan D SchoenfeldPublished in: Head & neck (2020)
Both B-CP and W-CP are well tolerated. PROs do not suggest a benefit to W-CP.